Navigation Links
Danish Hotspot in Personalized Medicine
Date:11/12/2007

COPENHAGEN, November 12 /PRNewswire/ -- The Danish biotech cluster known as Medicon Valley has, within a short period, grown into a global hotspot in the field of personalized medicine, and finds itself increasingly in favor among big pharma and big biotech. Experience Danish competencies at the 3rd Annual Personalized Medicine Meeting in San Francisco from 12th - 13th November.

With over 10 research institutions and 15-20 private companies engaged in personalized medicine, the Danish biotech cluster known as Medicon Valley has in record time become a strong player in currently one of the hottest research fields within the pharmaceutical industry.

Several of these Danish players operate on an individual basis, although many are also involved in collaborative research efforts, including the Danish Center for Translational Breast Cancer Research, the siRNA Delivery Center, the Danish microRNA consortium and special research departments at the University of Copenhagen and the Technical University of Denmark.

This is one reason why Denmark is participating in 3rd Annual Personalized Medicine Meeting in San Francisco, where Director of Knowledge and Communications at Danish Medicines Agency Kaare Geil is in the panel discussion on the second day to give a European/Danish perspective on the topic: Who Will Pay? The Economics of Personalized Medicine. Kaare Geil says: "Denmark has a national cancer plan, which is very clear on personalized medicine. The ministry of health as well as the ministry of science, has specific programs to support and enable the implementation of personalized medicines in our systems."

S0ren M. Echwald, M.Sc., Ph.D., who is Vice President and responsible for Business Development at Exiqon will be hosting a table discussion at the conference. "Exiqon is very committed to our diagnostic vision, and is active with several diagnostic projects," says S0ren M. Echwald. "With Exqion's key technologies, the growing role of microRNA in classification of cancers, and the strong clinical network in Scandinavia, we feel ideally positioned to contribute to the improvement of cancer treatment selection."

Business Development Manager Vibeke Dalhoff from Copenhagen Capacity, the official investment promotion agency of the Capital Region of Denmark explains: "Denmark is absolutely world-class within biomedicine and we are pioneers within personalized medicine, with strong competencies in the therapeutic and cancer fields, among others."

Gitte Pedersen, special advisor with the sister organization Invest in Denmark: "Denmark is in a unique position. We excel at developing medicine, we have core competencies within system biology, which is the toolbox for personalized medicine, and we have a health service that can see the advantages of implementing individualized medicine and engage in an open dialog between companies and the authorities".

Given this cocktail of companies, research environment and interest from the public sector, international pharmaceutical companies working on personalized medicine have a strong focus on Denmark and Medicon Valley.

"There is growing interest in the Danish competencies within individualized medicine", says Vibeke Dalhoff.

These companies work with personalized medicine in Denmark:

Within diagnostics: Dako, Exiqon, FluimediX and Medical Prognostic Institute.

Within drug discovery: Genmab, Novo Nordisk, Pharmexa, Santaris Pharma and TopoTarget.

For further information:

Vibeke Dalhoff

Tel.:+45-33-26-87-22

+45-61-26-464

email: vda@copcap.com

Gitte Pedersen

tel: +1-212-665-8626

email: gp@investindk.com


'/>"/>
SOURCE Copenhagen Capacity
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. The 3rd Annual Burrill Personalized Medicine Meeting November 12-13, 2007 in San Francisco
2. HHS Issues First Department-Wide Report on Personalized Health Care
3. Agendia Joins the Personalized Medicine Coalition (PMC)
4. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
5. Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers
6. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
7. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
8. Nobel Award in Medicine Holds Strong Messsage for Animal Activists
9. Companys Partner Completes Trial Production of a New Antiviral Medicine
10. Luminex Corporation Reaches Settlement With Rules Based Medicine, Inc.
11. Pioneer in Reproductive Medicine Opens The Countrys First Comprehensive Fertility Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... ... January 12, 2017 , ... After ... Lisa Rosendahl’s doctors gave her only a few months to live. Now a ... that has stabilized Rosendahl’s disease and increased both the quantity and quality of ...
(Date:1/12/2017)... Jan. 12, 2017   Protein Sciences Corporation ... of Flublok Influenza Vaccine ®, announced today ... had good safety results and induced strong neutralizing ... The product is expected to advance into human ... addition, the Institute of Technology in Immunobiologicals of ...
(Date:1/12/2017)... 2017 The report "Direct-Fed Microbials Market by Type (Lactic Acid Bacteria ... and Region - Global Forecast to 2022", published by MarketsandMarkets, the global market ... to reach USD 1,399.6 Million by 2022, at a CAGR of 6.96% from ... ... MarketsandMarkets Logo ...
(Date:1/11/2017)... (PRWEB) , ... January 11, 2017 , ... ... journal Clinical Cancer Research show early promise of the investigational anti-cancer agent tucatinib ... a median 5 previous treatment regimens. Twenty-seven percent of these heavily pretreated patients ...
Breaking Biology Technology:
(Date:12/15/2016)... Dec. 15, 2016 Advancements in ... health wellness and wellbeing (HWW), and security ... three new passenger vehicles begin to feature ... recognition, heart beat monitoring, brain wave monitoring, ... monitoring, and pulse detection. These will be ...
(Date:12/8/2016)... 2016 Market Research Future published a half cooked research ... Biometric Security and Service Market is expected to grow over the ... Market Highlights: ... Mobile Biometric Security and Service Market ... need of authentication and security from unwanted cyber threats. The increasing ...
(Date:12/7/2016)... --  Avanade is helping Williams Martini Racing, one ... exploit biometric data in order to critically analyse every ... edge against their rivals after their impressive, record-breaking pit ... worked with Williams during the 2016 season to capture ... breathing rate, temperature and peak acceleration) for key members ...
Breaking Biology News(10 mins):